HHL:CA:TSX-Harvest Healthcare Leaders Income ETF (CAD)

ETF | Sector Equity |

Last Closing

CAD 8.65

Change

-0.07 (-0.80)%

Market Cap

N/A

Volume

0.17M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-03 )

Largest Industry Peers for Sector Equity

Symbol Name Price(Change) Market Cap
TEC:CA TD Global Technology Leaders I..

+0.25 (+0.63%)

CAD 2.91B
ZWU:CA BMO Covered Call Utilities ETF

-0.04 (-0.36%)

CAD 1.94B
XHC:CA iShares Global Healthcare (CAD..

-0.69 (-0.92%)

CAD 0.65B
XIT:CA iShares S&P/TSX Capped Informa..

-0.19 (-0.33%)

CAD 0.65B
TXF:CA First Asset Tech Giants Covere..

+0.08 (+0.35%)

CAD 0.65B
HTA:CA Harvest Tech Achievers Growth ..

+0.08 (+0.40%)

CAD 0.63B
ZUT:CA BMO Equal Weight Utilities Ind..

-0.30 (-1.32%)

CAD 0.45B
CWW:CA iShares Global Water Common Cl..

+0.09 (+0.15%)

CAD 0.34B
XUT:CA iShares S&P/TSX Capped Utiliti..

-0.37 (-1.30%)

CAD 0.32B
COW:CA iShares Global Agriculture Com..

-0.74 (-1.17%)

CAD 0.28B

ETFs Containing HHL:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Sector Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 7.72% 34% F 41% F
Dividend Return 6.60% 100% F 96% N/A
Total Return 14.32% 66% D+ 56% F
Trailing 12 Months  
Capital Gain 12.34% 29% F 37% F
Dividend Return 9.15% 93% A 97% N/A
Total Return 21.49% 43% F 50% F
Trailing 5 Years  
Capital Gain 17.85% 29% F 49% F
Dividend Return 35.81% 100% F 96% N/A
Total Return 53.66% 43% F 64% D
Average Annual (5 Year Horizon)  
Capital Gain 2.14% N/A N/A 46% F
Dividend Return 8.83% N/A N/A 62% D
Total Return 6.69% N/A N/A 98% N/A
Risk Return Profile  
Volatility (Standard Deviation) 8.86% N/A N/A 55% F
Risk Adjusted Return 99.63% N/A N/A 96% N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike